Example: Heart Attack

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Total 9779 results

NCT00202995

Terminated

Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS

Relapsing Remitting Multiple Sclerosis
NCT00668343

Completed

Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)

Relapsing Remitting Multiple Sclerosis
NCT01085721

Unknown

Comparison Between Dexchlorpheniramine and Dexchlorpheniramine/Pseudoephedrine/Guaifenesin in Respiratory Infections

Viral Infections of the Upper Respiratory Tract
NCT00859482

Completed

Differential Immune Effects of Natalizumab

Multiple Sclerosis, Relapsing Remitting
NCT00382629

Completed

BHT-3009 Immunotherapy in Relapsing Remitting Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
NCT07596901

Recruiting

Study of Aritinercept in Patients With Generalized Myasthenia Gravis

Myasthenia Gravis, Generalized
NCT07592754

Not yet recruiting

The Safety and Efficacy of KSVCBD Injection in Neuromyelitis Optica Spectrum Disorder.

Neuromyelitis Optica Spectrum Disease (NMOSD)
NCT07562074

Not yet recruiting

Transcranial Magnetic Stimulation for Depression in Multiple Sclerosis

Multiple Sclerosis | Fatigue | Depression - Major Depressive Disorder
NCT07557420

Not yet recruiting

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Neuromyelitis Optica Spectrum Disorder | NMOSD
NCT07501702

Recruiting

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis (ETNA)

Myasthenia Gravis, Generalized
NCT07463521

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis (MyVision)

Ocular Myasthenia Gravis
NCT07465289

Not yet recruiting

A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

Ocular Myasthenia Gravis
NCT07425054

Not yet recruiting

HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer

Anal Cancer | HPV-Related Carcinoma | Squamous Cell Carcinoma of the Anus
NCT07420296

Recruiting

Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder (ELITE)

Neuromyelitis Optica Spectrum Disorders (NMOSD)
NCT07337395

Not yet recruiting

Proteomic Changes in Patients With Myasthenia Gravis and Ravulizumab (PROMPT)

Myasthenia Gravis Generalised
NCT07249632

Recruiting

A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)

Myasthenia Gravis, Ocular
NCT07226830

Not yet recruiting

Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG (BioDigit MG-03)

Myasthenia Gravis Generalized
NCT07215650

Recruiting

Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

Generalized Myasthenia Gravis
NCT06715436

Recruiting

Multiple Sclerosis and the Effects of Ketogenic Diet Therapy

Multiple Sclerosis, Relapsing-Remitting
NCT06159712

Recruiting

Comparative Study of High-Efficacy Disease Modifying Treatment of Relapsing Multiple Sclerosis (CoSHEDRMS)

Relapsing Remitting Multiple Sclerosis
NCT05519553

Not yet recruiting

Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis (PAIR-SEP)

Multiple Sclerosis, Relapsing-remitting
NCT05285891

Recruiting

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis (AMS05)

Multiple Sclerosis
NCT05019820

Recruiting

Identification of Sarcopenia in Knee Osteoarthritis With Ultrasonography and Evaluation of Muscle Architecture Change by Ultrasonography After Isokinetic Exercise Program

Sarcopenia | Osteoarthritis of the Knee
NCT04936581

Recruiting

Patient Reported Outcomes Following Cancer of the Rectum (PROCaRe)

Rectal Cancer | Sphincter Ani Incontinence
NCT04604041

Recruiting

Investigation of Subclinical Markers of Multiple Sclerosis (SUBCLIN-MS)

Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis
NCT04532944

Completed

The Energetic Origin of Neurodegeneration in MS (ENERGYSEP)

Multiple Sclerosis
NCT07184840

Active, not recruiting

Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder (EASE-NMO)

Neuromyelitis Optica Spectrum Disorder Attack
NCT01442233

Completed

Plasma Exchanges in Multiple Sclerosis (MS) Relapses (PLASMASEP)

Multiple Sclerosis | Multiple Sclerosis, Acute Relapsing
NCT06588491

Active, not recruiting

KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome

Stiff-Person Syndrome | SPS
NCT06672484

Active, not recruiting

Walking Fatigability and Brain Activity in People With Multiple Sclerosis

Multiple Sclerosis | Healthy
NCT05870254

Completed

Exergaming With Immersive Virtual Reality For People With Multiple Sclerosis (ExeRVIEM) (ExeRVIEM)

Multiple Sclerosis | Exercise | Rehabilitation | Physical Therapy | Virtual Reality Exposure Therapy
NCT06987994

Completed

The Effect of Virtual Reality on Fatigue and Functional Capacity in Patients With MS (VRMS)

Multiple Sclerosis | Virtual Reality | Multiple Sclerosis (MS) - Relapsing-remitting
NCT06176612

Completed

In Patients With Hip Dysplasia, Mid-Term Lower Extremities and Spine After Hip Arthroplasty Natural Course

Total Hip Arthroplasty
NCT01006265

Completed

Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of ACT-128800 in Patients With Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis
NCT01093326

Completed

Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis

Multiple Sclerosis
NCT03498131

Completed

Melatonin in Patients With Multiple Sclerosis (MS).

Relapsing Remitting Multiple Sclerosis
NCT06718478

Completed

First in Human Study of SakuraBead for Genicular Artery Embolization to Treat Pain Secondary to Knee Osteoarthritis

Arthritis | Joint Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Osteoarthritis | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee Pain
NCT05367947

Completed

In-phase Bilateral Exercises in People With Relapsing Remitting Multiple Sclerosis

Multiple Sclerosis
NCT03539094

Completed

Intermittent Fasting in Multiple Sclerosis (IFMS)

Relapsing Remitting Multiple Sclerosis
NCT05821257

Completed

Arm Swing During Walking in Early Multiple Sclerosis

Multiple Sclerosis | Gait Disorders, Neurologic | Upper Extremity Problem
NCT01606137

Completed

A Study of the Long-term Safety of Sativex Use

Pain | Multiple Sclerosis | Spasticity
NCT04225312

Enrolling by invitation

Personalized Extended Interval Dosing of Natalizumab in Relapsing Remitting Multiple Sclerosis (SUPERNEXT)

Relapsing Remitting Multiple Sclerosis
NCT02253810

Completed

Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy

Dysplasia, Congenital Hip
NCT01490502

Completed

Vitamin D Supplementation in Multiple Sclerosis

Relapsing Remitting Multiple Sclerosis
NCT02634307

Completed

A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1

Multiple Sclerosis
NCT03718247

Completed

Utilization of the Ketogenic Diet in Patient With Relapsing Remitting MS

Relapsing Remitting Multiple Sclerosis
NCT00605215

Completed

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®) (BRAVO)

Multiple Sclerosis
NCT01067521

Completed

A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to Placebo (GALA)

Relapsing Remitting Multiple Sclerosis
NCT01707992

Completed

The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) (CONCERTO)

Multiple Sclerosis
NCT04550611

Unknown

Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome

Guillain-Barre Syndrome

Clinical Trials on Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations